ArticleBMC cancer2017

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.

Dennis C Harrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.